HEADER HYDROLASE 15-DEC-03 1RVY TITLE E75Q MUTANT OF RABBIT CYTOSOLIC SERINE HYDROXYMETHYLTRANSFERASE, TITLE 2 COMPLEX WITH GLYCINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE HYDROXYMETHYLTRANSFERASE, CYTOSOLIC; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: SERINE METHYLASE, GLYCINE HYDROXYMETHYLTRANSFERASE, SHMT; COMPND 5 EC: 2.1.2.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ORYCTOLAGUS CUNICULUS; SOURCE 3 ORGANISM_COMMON: RABBIT; SOURCE 4 ORGANISM_TAXID: 9986; SOURCE 5 GENE: SHMT1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET22B KEYWDS ONE CARBON METABOLISM, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR D.M.SZEBENYI,F.N.MUSAYEV,M.L.DI SALVO,M.K.SAFO,V.SCHIRCH REVDAT 6 23-AUG-23 1RVY 1 REMARK REVDAT 5 27-OCT-21 1RVY 1 REMARK SEQADV LINK REVDAT 4 21-SEP-16 1RVY 1 REMARK REVDAT 3 13-JUL-11 1RVY 1 VERSN REVDAT 2 24-FEB-09 1RVY 1 VERSN REVDAT 1 15-JUN-04 1RVY 0 JRNL AUTH D.M.SZEBENYI,F.N.MUSAYEV,M.L.DI SALVO,M.K.SAFO,V.SCHIRCH JRNL TITL SERINE HYDROXYMETHYLTRANSFERASE: ROLE OF GLU75 AND EVIDENCE JRNL TITL 2 THAT SERINE IS CLEAVED BY A RETROALDOL MECHANISM. JRNL REF BIOCHEMISTRY V. 43 6865 2004 JRNL REFN ISSN 0006-2960 JRNL PMID 15170323 JRNL DOI 10.1021/BI049791Y REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.16 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 4024355.570 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.7 REMARK 3 NUMBER OF REFLECTIONS : 22026 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.283 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.600 REMARK 3 FREE R VALUE TEST SET COUNT : 1242 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.08 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3679 REMARK 3 BIN R VALUE (WORKING SET) : 0.2880 REMARK 3 BIN FREE R VALUE : 0.3710 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 199 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.026 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7186 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 102 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.51000 REMARK 3 B22 (A**2) : -5.51000 REMARK 3 B33 (A**2) : 11.02000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.41 REMARK 3 ESD FROM SIGMAA (A) : 0.37 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.52 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.55 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.800 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : GROUP REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.26 REMARK 3 BSOL : 10.68 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : PLS2.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : PLS.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : WATER.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: SOLVENT MOLECULES CARRIED OVER FROM REMARK 3 (HIGHER RESOLUTION) UNLIGANDED STRUCTURE REMARK 4 REMARK 4 1RVY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-DEC-03. REMARK 100 THE DEPOSITION ID IS D_1000021075. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-MAR-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS II REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DPS, MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22342 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 27.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 200 DATA REDUNDANCY : 5.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.18800 REMARK 200 FOR THE DATA SET : 3.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.06 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.62600 REMARK 200 FOR SHELL : 1.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: RIGID BODY REFINEMENT OF REMARK 200 UNLIGANDED E75Q RCSHMT STRUCTURE REMARK 200 SOFTWARE USED: CNS 1.1 REMARK 200 STARTING MODEL: PDB ENTRY 1RVU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.38 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, KCL, KMES, PH 6.4, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298.K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 78.18500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 57.35000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 57.35000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 39.09250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 57.35000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 57.35000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 117.27750 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 57.35000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 57.35000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 39.09250 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 57.35000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 57.35000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 117.27750 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 78.18500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASYMMETRIC UNIT CONTAINS A HOMODIMER. THE BIOLOGICAL REMARK 300 ASSEMBLY IS A TETRAMER CONSISTING OF A PAIR OF DIMERS. THE SECOND REMARK 300 DIMER IN THE TETRAMER IS GENERATED BY THE OPERATION: Y,X,1-Z. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 156.37000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 2 REMARK 465 THR A 3 REMARK 465 ALA A 4 REMARK 465 VAL A 5 REMARK 465 ASN A 6 REMARK 465 GLY A 7 REMARK 465 ALA A 8 REMARK 465 PRO A 9 REMARK 465 ARG A 10 REMARK 465 ASP A 11 REMARK 465 ALA A 12 REMARK 465 ALA A 13 REMARK 465 LEU A 14 REMARK 465 VAL A 276 REMARK 465 ASP A 277 REMARK 465 PRO A 278 REMARK 465 LYS A 279 REMARK 465 THR A 280 REMARK 465 GLY A 281 REMARK 465 LYS A 282 REMARK 465 ALA B 2 REMARK 465 THR B 3 REMARK 465 ALA B 4 REMARK 465 VAL B 5 REMARK 465 ASN B 6 REMARK 465 GLY B 7 REMARK 465 ALA B 8 REMARK 465 PRO B 9 REMARK 465 ARG B 10 REMARK 465 ASP B 11 REMARK 465 ALA B 12 REMARK 465 ALA B 13 REMARK 465 LEU B 14 REMARK 465 PRO B 278 REMARK 465 LYS B 279 REMARK 465 THR B 280 REMARK 465 GLY B 281 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 460 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 ARG A 460 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 19 -70.87 -65.28 REMARK 500 GLN A 20 -38.03 -35.97 REMARK 500 SER A 67 173.19 -58.45 REMARK 500 SER A 74 43.93 -143.75 REMARK 500 GLN A 80 51.60 -140.98 REMARK 500 PRO A 108 -6.19 -52.02 REMARK 500 VAL A 132 -65.55 -90.40 REMARK 500 GLU A 133 155.63 88.74 REMARK 500 PRO A 134 121.88 -37.52 REMARK 500 THR A 150 -9.45 -54.87 REMARK 500 PHE A 153 103.29 -162.46 REMARK 500 CYS A 204 73.67 -154.13 REMARK 500 HIS A 256 -143.67 -99.28 REMARK 500 LYS A 257 -125.53 58.98 REMARK 500 ALA A 264 -174.78 -171.40 REMARK 500 GLU A 289 -70.96 -40.42 REMARK 500 THR A 351 8.54 81.49 REMARK 500 ASN A 356 -141.52 -137.51 REMARK 500 SER A 365 13.06 -68.27 REMARK 500 ASN A 387 124.07 -179.62 REMARK 500 ASP A 392 117.90 7.80 REMARK 500 LEU A 396 30.95 -99.91 REMARK 500 ARG A 397 59.27 -177.05 REMARK 500 PRO A 441 -27.00 -38.54 REMARK 500 ALA A 443 144.79 -178.08 REMARK 500 ASP A 455 109.43 173.84 REMARK 500 HIS A 458 -71.20 -84.18 REMARK 500 PRO A 479 158.20 -44.55 REMARK 500 PRO A 482 -103.51 -9.02 REMARK 500 GLN B 24 107.88 -17.02 REMARK 500 PRO B 25 161.55 -45.81 REMARK 500 SER B 67 173.29 -58.79 REMARK 500 SER B 74 49.86 -147.69 REMARK 500 PRO B 108 -4.98 -52.12 REMARK 500 VAL B 132 -64.86 -90.30 REMARK 500 GLU B 133 155.47 88.76 REMARK 500 PRO B 134 121.95 -38.40 REMARK 500 THR B 150 -8.96 -54.80 REMARK 500 PHE B 153 103.20 -162.58 REMARK 500 CYS B 204 75.62 -153.91 REMARK 500 HIS B 256 -143.29 -98.86 REMARK 500 LYS B 257 -125.94 58.54 REMARK 500 VAL B 276 -142.18 -85.00 REMARK 500 GLU B 289 -70.95 -41.15 REMARK 500 ASN B 356 -141.60 -136.99 REMARK 500 SER B 365 12.22 -66.69 REMARK 500 ASN B 387 124.54 -179.39 REMARK 500 ASP B 392 118.19 7.62 REMARK 500 ARG B 397 59.19 -178.62 REMARK 500 ARG B 442 50.08 -112.39 REMARK 500 REMARK 500 THIS ENTRY HAS 52 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PLG A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PLP B 600 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1CJ0 RELATED DB: PDB REMARK 900 WILD-TYPE RABBIT CSHMT. REMARK 900 RELATED ID: 1LS3 RELATED DB: PDB REMARK 900 WILD-TYPE RABBIT CSHMT IN COMPLEX WITH GLYCINE AND 5- REMARK 900 FORMYLTETRAHYDROPTEROYLTRIGLUTAMATE. REMARK 900 RELATED ID: 1RV4 RELATED DB: PDB REMARK 900 E75L MUTANT OF RABBIT CSHMT. REMARK 900 RELATED ID: 1RVU RELATED DB: PDB REMARK 900 E75Q MUTANT OF RABBIT CSHMT, UNLIGANDED. DBREF 1RVY A 2 484 UNP P07511 GLYC_RABIT 1 483 DBREF 1RVY B 2 484 UNP P07511 GLYC_RABIT 1 483 SEQADV 1RVY GLN A 75 UNP P07511 GLU 74 ENGINEERED MUTATION SEQADV 1RVY GLN B 75 UNP P07511 GLU 74 ENGINEERED MUTATION SEQRES 1 A 483 ALA THR ALA VAL ASN GLY ALA PRO ARG ASP ALA ALA LEU SEQRES 2 A 483 TRP SER SER HIS GLU GLN MET LEU ALA GLN PRO LEU LYS SEQRES 3 A 483 ASP SER ASP ALA GLU VAL TYR ASP ILE ILE LYS LYS GLU SEQRES 4 A 483 SER ASN ARG GLN ARG VAL GLY LEU GLU LEU ILE ALA SER SEQRES 5 A 483 GLU ASN PHE ALA SER ARG ALA VAL LEU GLU ALA LEU GLY SEQRES 6 A 483 SER CYS LEU ASN ASN LYS TYR SER GLN GLY TYR PRO GLY SEQRES 7 A 483 GLN ARG TYR TYR GLY GLY THR GLU HIS ILE ASP GLU LEU SEQRES 8 A 483 GLU THR LEU CYS GLN LYS ARG ALA LEU GLN ALA TYR GLY SEQRES 9 A 483 LEU ASP PRO GLN CYS TRP GLY VAL ASN VAL GLN PRO TYR SEQRES 10 A 483 SER GLY SER PRO ALA ASN PHE ALA VAL TYR THR ALA LEU SEQRES 11 A 483 VAL GLU PRO HIS GLY ARG ILE MET GLY LEU ASP LEU PRO SEQRES 12 A 483 ASP GLY GLY HIS LEU THR HIS GLY PHE MET THR ASP LYS SEQRES 13 A 483 LYS LYS ILE SER ALA THR SER ILE PHE PHE GLU SER MET SEQRES 14 A 483 ALA TYR LYS VAL ASN PRO ASP THR GLY TYR ILE ASP TYR SEQRES 15 A 483 ASP ARG LEU GLU GLU ASN ALA ARG LEU PHE HIS PRO LYS SEQRES 16 A 483 LEU ILE ILE ALA GLY THR SER CYS TYR SER ARG ASN LEU SEQRES 17 A 483 ASP TYR GLY ARG LEU ARG LYS ILE ALA ASP GLU ASN GLY SEQRES 18 A 483 ALA TYR LEU MET ALA ASP MET ALA HIS ILE SER GLY LEU SEQRES 19 A 483 VAL VAL ALA GLY VAL VAL PRO SER PRO PHE GLU HIS CYS SEQRES 20 A 483 HIS VAL VAL THR THR THR THR HIS LYS THR LEU ARG GLY SEQRES 21 A 483 CYS ARG ALA GLY MET ILE PHE TYR ARG ARG GLY VAL ARG SEQRES 22 A 483 SER VAL ASP PRO LYS THR GLY LYS GLU ILE LEU TYR ASN SEQRES 23 A 483 LEU GLU SER LEU ILE ASN SER ALA VAL PHE PRO GLY LEU SEQRES 24 A 483 GLN GLY GLY PRO HIS ASN HIS ALA ILE ALA GLY VAL ALA SEQRES 25 A 483 VAL ALA LEU LYS GLN ALA MET THR PRO GLU PHE LYS GLU SEQRES 26 A 483 TYR GLN ARG GLN VAL VAL ALA ASN CYS ARG ALA LEU SER SEQRES 27 A 483 ALA ALA LEU VAL GLU LEU GLY TYR LYS ILE VAL THR GLY SEQRES 28 A 483 GLY SER ASP ASN HIS LEU ILE LEU VAL ASP LEU ARG SER SEQRES 29 A 483 LYS GLY THR ASP GLY GLY ARG ALA GLU LYS VAL LEU GLU SEQRES 30 A 483 ALA CYS SER ILE ALA CYS ASN LYS ASN THR CYS PRO GLY SEQRES 31 A 483 ASP LYS SER ALA LEU ARG PRO SER GLY LEU ARG LEU GLY SEQRES 32 A 483 THR PRO ALA LEU THR SER ARG GLY LEU LEU GLU LYS ASP SEQRES 33 A 483 PHE GLN LYS VAL ALA HIS PHE ILE HIS ARG GLY ILE GLU SEQRES 34 A 483 LEU THR VAL GLN ILE GLN ASP ASP THR GLY PRO ARG ALA SEQRES 35 A 483 THR LEU LYS GLU PHE LYS GLU LYS LEU ALA GLY ASP GLU SEQRES 36 A 483 LYS HIS GLN ARG ALA VAL ARG ALA LEU ARG GLN GLU VAL SEQRES 37 A 483 GLU SER PHE ALA ALA LEU PHE PRO LEU PRO GLY LEU PRO SEQRES 38 A 483 GLY PHE SEQRES 1 B 483 ALA THR ALA VAL ASN GLY ALA PRO ARG ASP ALA ALA LEU SEQRES 2 B 483 TRP SER SER HIS GLU GLN MET LEU ALA GLN PRO LEU LYS SEQRES 3 B 483 ASP SER ASP ALA GLU VAL TYR ASP ILE ILE LYS LYS GLU SEQRES 4 B 483 SER ASN ARG GLN ARG VAL GLY LEU GLU LEU ILE ALA SER SEQRES 5 B 483 GLU ASN PHE ALA SER ARG ALA VAL LEU GLU ALA LEU GLY SEQRES 6 B 483 SER CYS LEU ASN ASN LYS TYR SER GLN GLY TYR PRO GLY SEQRES 7 B 483 GLN ARG TYR TYR GLY GLY THR GLU HIS ILE ASP GLU LEU SEQRES 8 B 483 GLU THR LEU CYS GLN LYS ARG ALA LEU GLN ALA TYR GLY SEQRES 9 B 483 LEU ASP PRO GLN CYS TRP GLY VAL ASN VAL GLN PRO TYR SEQRES 10 B 483 SER GLY SER PRO ALA ASN PHE ALA VAL TYR THR ALA LEU SEQRES 11 B 483 VAL GLU PRO HIS GLY ARG ILE MET GLY LEU ASP LEU PRO SEQRES 12 B 483 ASP GLY GLY HIS LEU THR HIS GLY PHE MET THR ASP LYS SEQRES 13 B 483 LYS LYS ILE SER ALA THR SER ILE PHE PHE GLU SER MET SEQRES 14 B 483 ALA TYR LYS VAL ASN PRO ASP THR GLY TYR ILE ASP TYR SEQRES 15 B 483 ASP ARG LEU GLU GLU ASN ALA ARG LEU PHE HIS PRO LYS SEQRES 16 B 483 LEU ILE ILE ALA GLY THR SER CYS TYR SER ARG ASN LEU SEQRES 17 B 483 ASP TYR GLY ARG LEU ARG LYS ILE ALA ASP GLU ASN GLY SEQRES 18 B 483 ALA TYR LEU MET ALA ASP MET ALA HIS ILE SER GLY LEU SEQRES 19 B 483 VAL VAL ALA GLY VAL VAL PRO SER PRO PHE GLU HIS CYS SEQRES 20 B 483 HIS VAL VAL THR THR THR THR HIS LYS THR LEU ARG GLY SEQRES 21 B 483 CYS ARG ALA GLY MET ILE PHE TYR ARG ARG GLY VAL ARG SEQRES 22 B 483 SER VAL ASP PRO LYS THR GLY LYS GLU ILE LEU TYR ASN SEQRES 23 B 483 LEU GLU SER LEU ILE ASN SER ALA VAL PHE PRO GLY LEU SEQRES 24 B 483 GLN GLY GLY PRO HIS ASN HIS ALA ILE ALA GLY VAL ALA SEQRES 25 B 483 VAL ALA LEU LYS GLN ALA MET THR PRO GLU PHE LYS GLU SEQRES 26 B 483 TYR GLN ARG GLN VAL VAL ALA ASN CYS ARG ALA LEU SER SEQRES 27 B 483 ALA ALA LEU VAL GLU LEU GLY TYR LYS ILE VAL THR GLY SEQRES 28 B 483 GLY SER ASP ASN HIS LEU ILE LEU VAL ASP LEU ARG SER SEQRES 29 B 483 LYS GLY THR ASP GLY GLY ARG ALA GLU LYS VAL LEU GLU SEQRES 30 B 483 ALA CYS SER ILE ALA CYS ASN LYS ASN THR CYS PRO GLY SEQRES 31 B 483 ASP LYS SER ALA LEU ARG PRO SER GLY LEU ARG LEU GLY SEQRES 32 B 483 THR PRO ALA LEU THR SER ARG GLY LEU LEU GLU LYS ASP SEQRES 33 B 483 PHE GLN LYS VAL ALA HIS PHE ILE HIS ARG GLY ILE GLU SEQRES 34 B 483 LEU THR VAL GLN ILE GLN ASP ASP THR GLY PRO ARG ALA SEQRES 35 B 483 THR LEU LYS GLU PHE LYS GLU LYS LEU ALA GLY ASP GLU SEQRES 36 B 483 LYS HIS GLN ARG ALA VAL ARG ALA LEU ARG GLN GLU VAL SEQRES 37 B 483 GLU SER PHE ALA ALA LEU PHE PRO LEU PRO GLY LEU PRO SEQRES 38 B 483 GLY PHE HET PLG A 500 40 HET PO4 B 601 5 HET PLP B 600 15 HETNAM PLG N-GLYCINE-[3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL- HETNAM 2 PLG PYRIDIN-4-YL-METHANE] HETNAM PO4 PHOSPHATE ION HETNAM PLP PYRIDOXAL-5'-PHOSPHATE HETSYN PLG N-PYRIDOXYL-GLYCINE-5-MONOPHOSPHATE HETSYN PLP VITAMIN B6 PHOSPHATE FORMUL 3 PLG C10 H15 N2 O7 P FORMUL 4 PO4 O4 P 3- FORMUL 5 PLP C8 H10 N O6 P FORMUL 6 HOH *102(H2 O) HELIX 1 1 TRP A 15 GLN A 24 1 10 HELIX 2 2 PRO A 25 ASP A 30 1 6 HELIX 3 3 ASP A 30 GLY A 47 1 18 HELIX 4 4 SER A 58 GLY A 66 1 9 HELIX 5 5 SER A 67 ASN A 71 5 5 HELIX 6 6 THR A 86 TYR A 104 1 19 HELIX 7 7 SER A 119 VAL A 132 1 14 HELIX 8 8 LEU A 143 GLY A 146 5 4 HELIX 9 9 HIS A 148 GLY A 152 5 5 HELIX 10 10 SER A 161 PHE A 167 1 7 HELIX 11 11 ASP A 182 HIS A 194 1 13 HELIX 12 12 ASP A 210 ASN A 221 1 12 HELIX 13 13 ILE A 232 GLY A 239 1 8 HELIX 14 14 SER A 243 HIS A 247 5 5 HELIX 15 15 HIS A 256 ARG A 260 5 5 HELIX 16 16 ASN A 287 PHE A 297 1 11 HELIX 17 17 HIS A 305 MET A 320 1 16 HELIX 18 18 THR A 321 LEU A 345 1 25 HELIX 19 19 ARG A 364 GLY A 367 5 4 HELIX 20 20 ASP A 369 CYS A 380 1 12 HELIX 21 21 THR A 405 ARG A 411 1 7 HELIX 22 22 LEU A 414 GLY A 440 1 27 HELIX 23 23 THR A 444 GLY A 454 1 11 HELIX 24 24 ASP A 455 LEU A 475 1 21 HELIX 25 25 SER B 16 LEU B 22 1 7 HELIX 26 26 PRO B 25 ASP B 30 1 6 HELIX 27 27 ASP B 30 GLY B 47 1 18 HELIX 28 28 SER B 58 GLY B 66 1 9 HELIX 29 29 SER B 67 ASN B 71 5 5 HELIX 30 30 THR B 86 TYR B 104 1 19 HELIX 31 31 SER B 119 VAL B 132 1 14 HELIX 32 32 LEU B 143 GLY B 146 5 4 HELIX 33 33 HIS B 148 GLY B 152 5 5 HELIX 34 34 SER B 161 PHE B 167 1 7 HELIX 35 35 ASP B 182 HIS B 194 1 13 HELIX 36 36 ASP B 210 ASN B 221 1 12 HELIX 37 37 ILE B 232 GLY B 239 1 8 HELIX 38 38 SER B 243 HIS B 247 5 5 HELIX 39 39 HIS B 256 ARG B 260 5 5 HELIX 40 40 ASN B 287 PHE B 297 1 11 HELIX 41 41 HIS B 305 MET B 320 1 16 HELIX 42 42 THR B 321 LEU B 345 1 25 HELIX 43 43 THR B 351 GLY B 353 5 3 HELIX 44 44 ARG B 364 GLY B 367 5 4 HELIX 45 45 ASP B 369 CYS B 380 1 12 HELIX 46 46 THR B 405 SER B 410 1 6 HELIX 47 47 LEU B 414 ASP B 437 1 24 HELIX 48 48 THR B 444 GLY B 454 1 11 HELIX 49 49 ASP B 455 LEU B 475 1 21 SHEET 1 A 2 LEU A 48 GLU A 49 0 SHEET 2 A 2 ILE A 382 ALA A 383 1 O ALA A 383 N LEU A 48 SHEET 1 B 2 GLY A 76 TYR A 77 0 SHEET 2 B 2 GLN A 80 ARG A 81 -1 O GLN A 80 N TYR A 77 SHEET 1 C 7 TRP A 111 ASN A 114 0 SHEET 2 C 7 GLY A 265 ARG A 270 -1 O TYR A 269 N GLY A 112 SHEET 3 C 7 VAL A 250 THR A 254 -1 N VAL A 251 O PHE A 268 SHEET 4 C 7 TYR A 224 ASP A 228 1 N ALA A 227 O THR A 252 SHEET 5 C 7 LEU A 197 GLY A 201 1 N ALA A 200 O MET A 226 SHEET 6 C 7 ARG A 137 LEU A 141 1 N MET A 139 O ILE A 199 SHEET 7 C 7 GLU A 168 TYR A 172 1 O GLU A 168 N ILE A 138 SHEET 1 D 4 LYS A 348 ILE A 349 0 SHEET 2 D 4 LEU A 358 ASP A 362 -1 O ASP A 362 N LYS A 348 SHEET 3 D 4 GLY A 400 GLY A 404 -1 O LEU A 401 N VAL A 361 SHEET 4 D 4 ASN A 385 ASN A 387 -1 N ASN A 385 O ARG A 402 SHEET 1 E 2 LEU B 48 GLU B 49 0 SHEET 2 E 2 ILE B 382 ALA B 383 1 O ALA B 383 N LEU B 48 SHEET 1 F 2 GLY B 76 TYR B 77 0 SHEET 2 F 2 GLN B 80 ARG B 81 -1 O GLN B 80 N TYR B 77 SHEET 1 G 7 TRP B 111 ASN B 114 0 SHEET 2 G 7 GLY B 265 ARG B 270 -1 O TYR B 269 N GLY B 112 SHEET 3 G 7 VAL B 250 THR B 254 -1 N VAL B 251 O PHE B 268 SHEET 4 G 7 TYR B 224 ASP B 228 1 N ALA B 227 O THR B 252 SHEET 5 G 7 LEU B 197 GLY B 201 1 N ALA B 200 O MET B 226 SHEET 6 G 7 ARG B 137 LEU B 141 1 N MET B 139 O ILE B 199 SHEET 7 G 7 GLU B 168 TYR B 172 1 O GLU B 168 N ILE B 138 SHEET 1 H 2 VAL B 273 SER B 275 0 SHEET 2 H 2 ILE B 284 LEU B 285 -1 O ILE B 284 N SER B 275 SHEET 1 I 4 LYS B 348 ILE B 349 0 SHEET 2 I 4 LEU B 358 ASP B 362 -1 O ASP B 362 N LYS B 348 SHEET 3 I 4 GLY B 400 GLY B 404 -1 O LEU B 401 N VAL B 361 SHEET 4 I 4 ASN B 385 ASN B 387 -1 N ASN B 385 O ARG B 402 LINK NZ ALYS A 257 C4AAPLG A 500 1555 1555 1.48 LINK NZ LYS B 257 C4A PLP B 600 1555 1555 1.48 CISPEP 1 PHE A 297 PRO A 298 0 0.27 CISPEP 2 PHE B 297 PRO B 298 0 0.16 SITE 1 AC1 9 TYR A 73 GLN A 75 TYR A 83 SER B 53 SITE 2 AC1 9 SER B 203 HIS B 231 LYS B 257 ARG B 402 SITE 3 AC1 9 PLP B 600 SITE 1 AC2 20 SER A 53 SER A 119 GLY A 120 SER A 121 SITE 2 AC2 20 ASN A 124 HIS A 148 SER A 203 ASP A 228 SITE 3 AC2 20 ALA A 230 HIS A 231 THR A 254 HIS A 256 SITE 4 AC2 20 LYS A 257 ARG A 402 HOH A 515 TYR B 73 SITE 5 AC2 20 GLN B 75 TYR B 83 GLY B 302 GLY B 303 SITE 1 AC3 15 TYR A 73 GLY A 302 GLY A 303 SER B 119 SITE 2 AC3 15 GLY B 120 SER B 121 HIS B 148 ASP B 228 SITE 3 AC3 15 ALA B 230 HIS B 231 THR B 254 HIS B 256 SITE 4 AC3 15 LYS B 257 PO4 B 601 HOH B 615 CRYST1 114.700 114.700 156.370 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008718 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008718 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006395 0.00000